FNY Investment Advisers’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-150
Closed -$18K 694
2022
Q2
$18K Hold
150
0.01% 343
2022
Q1
$17K Buy
+150
New +$24.8K 0.02% 379
2021
Q2
Sell
-63
Closed -$24K 827
2021
Q1
$24K Buy
+63
New +$28.4K 0.01% 504

Other funds holding DRIO

FNY Investment Advisers's DRIO Position: Q3 2022 in Review

FNY Investment Advisers sold out of DarioHealth (DRIO) in Q3 2022, closing a stake of 150 shares — an estimated $18K sold.

FNY Investment Advisers first reported a position in DRIO in Q1 2021 and held it in 3 quarters. The position peaked at $24K in Q1 2021. 45 funds tracked by Wall St. Rank hold DRIO as of Q3 2022.

  • FNY Investment Advisers reported no remaining DarioHealth position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 150 DarioHealth shares in Q3 2022, an estimated $18K.
  • FNY Investment Advisers first reported a position in DarioHealth in Q1 2021 and held it in 3 quarters.
  • FNY Investment Advisers's DarioHealth position peaked at $24K in Q1 2021.
  • 45 funds tracked by Wall St. Rank held DarioHealth as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.